Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_assertion type Assertion NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_head.
- NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_assertion description "[Additionally, a recent study revealed a possible beneficial effect of antihuman CD20 antibody (rituximab) therapy for SSc patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_provenance.
- NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_assertion evidence source_evidence_literature NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_provenance.
- NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_assertion SIO_000772 20175836 NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_provenance.
- NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_assertion wasDerivedFrom befree-20140225 NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_provenance.
- NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_assertion wasGeneratedBy ECO_0000203 NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_provenance.